Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mediogen is a South Korean biotechnology company specializing in the development and manufacturing of functional probiotics and microbiome-based solutions. The company is a leader in the isolation and characterization of lactic acid bacteria, with a particular emphasis on strains derived from the vaginal microbiome for women's health applications. Mediogen operates as a full-service Contract Development and Manufacturing Organization (CDMO), offering expertise in strain development, fermentation, and specialized coating technologies to ensure probiotic stability. Their proprietary SP (Specialized Probiotics) coating technology enhances the survival rate of bacteria through the gastrointestinal tract. The company's product portfolio includes functional ingredients for weight management, immune support, and metabolic health. Mediogen serves a global client base, providing both raw materials and finished dosage forms for the nutraceutical and pharmaceutical industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mediogen.